TERF2IP and cancer: The removal of RAP1 from several human cancer cell lines, including cervical cancer (HeLa), fibrosarcoma (HT1080), and colon cancer (HTC116), through transcription activator-like effector nuclease (TALEN) did not appear to affect telomere length dynamics [22].